These Three Toilet Detection Health Technology Will Be In The United States, Izraēla, Japan Clinical Trials

Virtuves un vannas istabas nozare Galvenie mediji Informācija par virtuvi un vannas istabu

Israeli digital health startup OutSense was awarded a number of key innovation patents for IoT technology, foreign media reported on June 23. The technology gains life-saving medical insights by analyzing human excrement. Uzņēmums ir iesniedzis trīs patentu sēriju, kas aptver tā medicīniskā tualetes sensora elementus.

The first OutSense patent is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet bowl to determine the optical signature of hidden blood in feces. Patents for this technology have been granted in the United States, Eiropā, Japāna un Ķīna. A second patent has been granted in Europe and applications are pending for this patent in other countries. It allows effective analysis of the spatial distribution of the many components of stool and traces of blood. Based on this analysis, OutSense tehnoloģija var identificēt asiņu avotu kuņģa-zarnu traktā. A third patent is pending for the technology, which detects urine dehydration components by analyzing urine and feces.

Saskaņā ar OutSense izpilddirektora Yfat Scialom teikto, he predicts that “ar digitālās medicīnas eksploziju. This kind of monitoring will become the norm.” OutSense says the technology, which has already been approved and is pending approval, will provide broad protection for a person’s health by non-invasively extracting hidden blood from feces and urine. Hidden blood is critical for detecting colorectal cancer, iekaisīgas zarnu slimības un urīnceļu infekcijas. Its solution includes a multispectral optical sensor, gaismas avots un autonoma skrīninga ierīce, kas ietver WiFi savienojumu. The device scans human feces and identifies the optical footprint of fecal and urine components. It sends the data to an artificial intelligence-based cloud analysis, which then provides signs of various diseases with great precision.

OutSense develops tools to diagnose abnormalities in human feces. Informācija iegūta no asins paraugiem, kopā ar papildu analīzi par laiku no asiņošanas līdz izdalīšanai, sniedz sīkāku informāciju par asiņošanas patoloģiju. Its specific patterns can determine whether the bleeding is from a fissure or hemorrhoid, or from a polyp, tumor or from an ulcer. In early June, OutSense paziņoja, ka CommuniCare, liels veselības aprūpes uzņēmums ar vairāk nekā 90 medical facilities in the United States, šogad sāks pilotēt savu tehnoloģiju. Papildus šim pilotam, OutSense plans to conduct clinical trials in Israel and Japan.